Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | PDK1 | Q15118 | 3/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.37 |
| ▸ | PDK3 | Q15120 | 3/20 | 0.37 |
| ▸ | PDK4 | Q16654 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30501925 | 0.82 | KCNN4 (0.44) | KCNN4ALDH1A1CYP1A2L3MBTL1HTR2A | |
| SCHEMBL785777 | 0.82 | KCNN4 (0.44) | KCNN4ALDH1A1CYP1A2L3MBTL1HTR2A | |
| SCHEMBL27504182 | 0.80 | ALDH1A1 (0.54) | ALDH1A1CYP1A2L3MBTL1KIF11HTT | |
| SCHEMBL22940 | 0.80 | HTR2A (0.42) | KCNN4ALDH1A1CYP1A2L3MBTL1HTR2A | |
| SCHEMBL21494916 | 0.80 | CYP1A2 (0.42) | ALDH1A1CYP1A2SMN1; SMN2POLBNPC1 | |
| SCHEMBL1417552 | 0.80 | KCNN4 (0.42) | KCNN4ALDH1A1CYP1A2L3MBTL1HTR2A | |
| SCHEMBL24542 | 0.80 | HTR2A (0.42) | KCNN4ALDH1A1CYP1A2L3MBTL1HTR2A | |
| SCHEMBL1417550 | 0.80 | KCNN4 (0.42) | KCNN4ALDH1A1CYP1A2L3MBTL1HTR2A | |
| SCHEMBL4900842 | 0.79 | KCNN4 (0.45) | KCNN4ALDH1A1CYP1A2HTR2AHTR2C | |
| SCHEMBL15125013 | 0.78 | KCNN4 (0.41) | KCNN4ALDH1A1CYP1A2L3MBTL1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7446200-B2 | Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I | USV, LTD. (IN) | 2008-11-04 | — | — | US | disclosed |
| EP-1848720-A1 | RAPID RESOLUTION PROCESS FOR CLOPIDOGREL BASE AND A PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE POLYMORPH - FORM I | USV LIMITED (IN) | 2007-10-31 | — | — | EP | disclosed |
| WO-2006087729-A1 | RAPID RESOLUTION PROCESS FOR CLOPIDOGREL BASE AND A PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE POLYMORPH - FORM I | USV LIMITED (IN) | 2006-08-24 | — | — | WO | disclosed |
| US-20060074242-A1 | Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I | USV LIMITED (IN) | 2006-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074242-A1 | Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I | SRR, P2RY11, CYP2C19 | KCNN4 3690/4885ALDH1A1 362/4885CYP1A2 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.